These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3565410)

  • 1. Effect of clinical pharmacists on drug prescribing in a primary-care clinic.
    Stergachis A; Fors M; Wagner EH; Sims DD; Penna P
    Am J Hosp Pharm; 1987 Mar; 44(3):525-9. PubMed ID: 3565410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic.
    Forstrom MJ; Ried LD; Stergachis AS; Corliss DA
    DICP; 1990 Mar; 24(3):304-9. PubMed ID: 2316237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving antiulcer agent prescribing in a health maintenance organization.
    Raisch DW; Bootman JL; Larson LN; McGhan WF
    Am J Hosp Pharm; 1990 Aug; 47(8):1766-73. PubMed ID: 2389782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacists help HMO cut drug costs.
    Knowlton CH; Knapp DA
    Am Pharm; 1994 Jan; NS34(1):36-42. PubMed ID: 8166034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients.
    McGhan WF; Stimmel GL; Hall TG; Gilman TM
    Med Care; 1983 Apr; 21(4):435-44. PubMed ID: 6843196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of two interventions for reducing outpatient prescribing costs.
    Steele MA; Bess DT; Franse VL; Graber SE
    DICP; 1989 Jun; 23(6):497-500. PubMed ID: 2500784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-guided academic detailing as part of a drug benefit program.
    Keys PW; Goetz CM; Keys PA; Sterchele JA; Snedden TM; Livengood BH
    Am J Health Syst Pharm; 1995 Oct; 52(20):2199-203; discussion 22034. PubMed ID: 8564590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counter sampling combined with medical provider education: do they alter prescribing behavior?
    Erramouspe J; Bailey JM; Cleveland KW; Casperson K; Hunt TL; Cady PS
    Consult Pharm; 2006 Aug; 21(8):636-42. PubMed ID: 17076590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documenting outpatient problem intervention activities of pharmacists in an HMO.
    Christensen DB; Campbell WH; Madsen S; Hartzema AG; Nudelman PM
    Med Care; 1981 Jan; 19(1):104-17. PubMed ID: 7464303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
    Benedetto SR; Sloan AS; Duncan BS
    Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary-control procedures in a staff-model health maintenance organization.
    Lyon RA
    Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an education and feedback intervention on group-model and network-model health maintenance organization physician prescribing behavior.
    Schectman JM; Kanwal NK; Schroth WS; Elinsky EG
    Med Care; 1995 Feb; 33(2):139-44. PubMed ID: 7837822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in prescription drug use in HMO and self-insured health plans.
    Wallack SS; Thomas CP; Martin TC; Ryan A
    Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer.
    Monane M; Matthias DM; Nagle BA; Kelly MA
    JAMA; 1998 Oct; 280(14):1249-52. PubMed ID: 9786375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of family physician prescribing: influence of the clinical pharmacist.
    Carter BL; Helling DK; Jones ME; Moessner H; Waterbury CA
    Drug Intell Clin Pharm; 1984 Oct; 18(10):817-21. PubMed ID: 6489164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
    Hardigan WD; Slywka GW; Eng HJ
    Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.